Infection
|
Infection
Caused by microorganisms
- Bacteria
- Viruses
- Fungi
- Protozoa
- Others
|
Mode Of Transmission
* Direct Contact
: eg. Venereal, Skin infections
* Air-borne : eg. RTI, Tuberculosis
* Faeco-Oral : eg. Diarrhoea, Typhoid
* Vectors : eg. Malaria
|
Incubation
Period
Time elapsing
between entry of organisms into the body and onset of clinical symptoms
|
Susceptibility
Factors
:
- Racial
- Alcoholism
- Diabetes
- Immunoglobulin deficiency
- Malnutrition
- Agranulocytosis
- Steroid administration
- Foreign body
- Immunization
|
Immunity
* Natural
* Acquired
|
Types
Of Infection
|
Etiologic
Agents
|
Skin
and subcutaneous
tissue
|
Staphylococcus
aureus
|
Sinusitis
|
Streptococcus
pneumoniae, Staph. aureus
|
Pharyngitis
|
Respiratory
viruses, Strep. pyogenes
|
Epiglottitis
|
H.
Influenzae
|
Otitis
media, mastoiditis
|
Strep.
pneumoniae, H. influenzae (children)
|
Pneumonitis
|
Strep.
pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis
|
Empyema
and lung abscess
|
Staph.
aureus, Anaerobic Streptococcus, Bacteroides, Fusobacterium
|
Bacterial
endocarditis
|
Streptococcus
viridans, Staph. aureus, Enterococcus
|
|
Common Bacteria
Gram
Positive
Cocci
: Streptococcus,
Staphylococci
Bacilli
: Corynebacterium,
Bacillus, Clostridium
Gram Negative
Cocci
: Neisseria
Bacilli
: Escherichia,
Salmonella, Shigella, Haemophilus, Klebsiella,
Proteus, Pseudomonas
|
Laboratory
Diagnosis Of Infection
1) Direct
microscopic examination
2) Culture
3) Immunologic methods
|
Antibacterial
Agents
Substances
which interfere with bacterial growth
|
Selection Of
An Antibacterial Agent
Based on
:
1) Evaluation of probable etiology of infection and likelihood of
susceptibility to the drug
2) Identification of causative organism and the degree of sensitivity
3) Nature of the drug - bactericidal / bacteriostatic
4) Severity of infection and general condition of patient
|
Selection
OfAn Antibacterial Agent (Contd…)
5) Site
of infection
6) Possibility of drug resistance
7) Risk of drug toxicity
8) History of previous allergy to the drug
9) Special situations eg., pregnancy
10) Cost of Therapy
|
Bactericidal/
Bacteriostatic
Bactericidal
|
Bacteriostatic
|
Penicillins
Cephalosporins
Aminoglycosides
Cotrimoxazole
Fluoroquinolones |
Sulphonamides
Tetracyclines
Chloramphenicol
Macrolides |
|
Penicillins
eg., Benzyl penicillin, Phenoxymethyl penicillin, Cloxacillin, Ampicillin,
Carbenicillin, Ticarcillin
* Penicillin
is derived from Penicillium notatum, others are semisynthetic derivatives
* Penicillins are known for efficacy and safety
* Possess beta-lactam ring and thiazolidine ring in nucleus (beta-lactam
antibiotics)
* Penicillins may be inactivated by variousbeta-lactamases
|
Cephalosporins
* Derived from
Cephalosporium acremonium
* Possess beta lactam ring and dihydrothiazine ring in nucleus (beta-lactam
antibiotics)
* Stability / inactivation by various beta-lactamases
|
Cephalosporins
First
Generation :
Cephalexin
Cefazolin
Cefadroxil
Cephradine
Cephalothin
|
Third
Generation : Cefotaxime
Cefoperazone
Ceftriaxone
Ceftazidime
Cefixime
Ceftizoxime
|
Second
Generation :
Cefoxitin
Cefuroxime
Cefaclor |
|
|
Macrolides
eg., Erythromycin, Roxithromycin, Azithromycin, Clarithromycin
* Orally administered
antibacterials, with good efficacy against gram positive bacteria
and some gram negative bacteria
* Particularly useful in RTI / ENT infections, skin & soft tissue
infections
* Bacteriostatic agents
|
Tetracyclines
eg., Tetracycline, Oxytetracycline, Doxycycline
* Bacteriostatic
agents
* Broad system coverage against gram positive & gram negative bacteria
and Chlamydia
|
Chloramphenicol
* Bacteriostatic
agent
* Broad spectrum
* Particularly useful in typhoid, but resistance and toxicity limits
its use today
|
Aminoglycosides
eg., Streptomycin, Kanamycin, Gentamicin, Tobramycin, Neomycin
* Broad spectrum
including Pseudomonas aeruginosa
* Bactericidal
* Used in hospital acquired infections
* Parenterally administered (except neomycin) systemic infections,
also used topically
* Streptomycin used in tuberculosis
|
Sulphonamides
eg., Sulphamethoxazole, Sulphaxazole, Sulphacetamide
* Inhibit conversion of PABA to folic acid
* Bactericidal
* Sulphamethoxazole in combination with trimethoprim for synergistic
bactericidal effects
|
Fluoroquinolones
eg., Ciprofloxacin, Norfloxacin, Ofloxacin, Sparfloxacin
* Structurally related to nalidixic acid with broader spectrum and less
resistance
* Broad spectrum, bactericidal
* Orally efficacy against Pseudomonas aeruginosa
|
Nitroimidazoles
eg., Metronidazole, Tinidazole, Secnidazole
* Antiprotozoal agents
* Effective against anaerobic bacteria
|
Drug Combinations
* As a temporary
expedient during investigation of an obscure illness
* To prevent bacterial resistance
* For synergistic effect
* Mixed infections
* Permit reduction dose of a potentiallytoxic drug
|